Spelling suggestions: "subject:"cplasma concentrations"" "subject:"8plasma concentrations""
1 |
Determination of kanamycin plasma concentrations using LC/MS and pharmacokinetics of kanamycin in patients with multidrug-resistant tuberculosis and in patients with multidrug-resistant tuberculosis co-infected with HIVAbaniwonda, Ibukunoluwa Mercy January 2012 (has links)
Magister Pharmaceuticae - MPharm / The aim of the study was to determine firstly, kanamycin plasma concentrations using liquid chromatography coupled with mass spectrometry (LC/MS); secondly, to investigate the PK parameters of kanamycin in patients infected with MDR-TB and in patients co-infected with MDR-TB and HIV; thirdly, to assess the influence of HIV infection and renal impairment on the PK of kanamycin and fourthly, to find out whether there is any interaction between antiretroviral drugs and kanamycin.
|
2 |
Ethionamide pharmacokinetics in multidrugresistant tuberculosis patients with and without HIVinfectionEzeukwu, Ifeoma Patricia January 2017 (has links)
Magister Pharmaceuticae - Mpharm / Many studies have investigated the pharmacokinetics (PK) of anti-tuberculosis drugs
in tuberculosis patients. However, currently in South Africa, no studies have been
done on ethionamide (ETH) PK in adult MDR-TB patients that are infected with HIV
and those without HIV infection. Therefore, the objective of this current study was
firstly, to find out ethionamide plasma concentration using the LC-MS method;
secondly, to evaluate and compare the pharmacokinetics of ethionamide in MDR-TB
patients infected with and without HIV infection; thirdly, to examine the effects of
ARVs and kidney impairment on the PK of ethionamide and fourthly, to find out the
consequence of sex and age on ETH PK parameters.
|
Page generated in 0.1382 seconds